Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material.
Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992.
For patients, we provide the latest patient information leaflets and training materials as well as the technical information for Berlin-Chemie products available in Germany via our Medical Hub.
Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.
Discover More about Global Responsibility
From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet
Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice.
Discover More about Global Partnering
Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.
Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.
Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.
Menarini Blog
Follow Us
We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.
Our Job Portal
Find out about our current vacancies at Berlin-Chemie directly on our career portal.
Gout
Gout is a metabolic disorder that causes inflammation in or around joints. It is one of the most prevalent forms of inflammatory arthritis in the industrialised world.1 The inflammation is triggered by deposits of uric acid crystals.
Uric acid is the end product of purine degradation. Purines are compounds found in important building blocks in the body and are also ingested with various foods such as red meat, sausage products or beer. The uric acid is then excreted by the kidneys. Under certain circumstances, however, uric acid crystals may form if a critical amount of uric acid is present in the body. These are then deposited in the joints and can subsequently lead to inflammation and pain. Impaired kidney function or a disorder of purine metabolism can cause high levels of uric acid to build up.
Gout may occur in acute attacks known as “flares”. Symptoms include redness, swelling and pain associated with these symptoms. It is therefore advisable to reduce high uric acid levels since chronic gout may be associated with recurring flares and/or painful arthritis. Tophi, a late stage of chronic gout, can lead to deformation of the joints.
Gout can be treated by a change in lifestyle, including a low-purine diet, and lowering the uric acid levels with drug treatment.
